| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
105,392 |
95,210 |
$4.07M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
30,945 |
30,786 |
$2.94M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
31,499 |
30,181 |
$2.82M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
85,126 |
79,574 |
$2.27M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
20,028 |
19,983 |
$2.20M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
24,727 |
22,452 |
$1.96M |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14,857 |
12,419 |
$1.85M |
| 99051 |
|
23,667 |
22,778 |
$1.75M |
| G9920 |
Screening performed and negative |
43,409 |
42,956 |
$1.12M |
| 92551 |
|
64,187 |
63,777 |
$874K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15,598 |
15,179 |
$674K |
| D1206 |
Topical application of fluoride varnish |
23,241 |
22,640 |
$512K |
| 87428 |
|
6,905 |
6,666 |
$508K |
| 99381 |
|
3,935 |
3,656 |
$379K |
| 99402 |
|
3,521 |
3,507 |
$263K |
| 99173 |
|
61,363 |
61,037 |
$249K |
| 99188 |
|
10,255 |
9,975 |
$225K |
| 85018 |
|
81,861 |
80,529 |
$206K |
| 90686 |
|
21,001 |
20,907 |
$196K |
| 90670 |
|
17,151 |
15,668 |
$176K |
| 80061 |
Lipid panel |
11,663 |
11,563 |
$160K |
| 90698 |
|
16,065 |
14,545 |
$153K |
| 90680 |
|
14,956 |
13,495 |
$142K |
| 90716 |
|
10,720 |
10,231 |
$113K |
| 83655 |
|
8,391 |
8,071 |
$109K |
| 90651 |
|
8,729 |
8,710 |
$101K |
| 90707 |
|
10,300 |
9,843 |
$101K |
| 90744 |
|
10,886 |
9,891 |
$99K |
| 90633 |
|
10,151 |
9,550 |
$95K |
| 96127 |
|
16,104 |
16,059 |
$95K |
| 90685 |
|
9,966 |
9,429 |
$92K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,051 |
6,930 |
$87K |
| 82962 |
|
31,505 |
30,647 |
$87K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,564 |
11,161 |
$86K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,415 |
5,965 |
$79K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
7,762 |
7,533 |
$77K |
| 87430 |
|
5,774 |
5,650 |
$70K |
| 94664 |
|
5,517 |
5,336 |
$64K |
| 90700 |
|
6,860 |
6,569 |
$63K |
| 90734 |
|
5,251 |
5,238 |
$53K |
| 90671 |
|
3,545 |
3,284 |
$46K |
| 90621 |
|
3,639 |
3,634 |
$43K |
| 90715 |
|
4,096 |
4,089 |
$38K |
| 99401 |
|
3,350 |
3,309 |
$36K |
| 90648 |
|
3,885 |
3,657 |
$35K |
| 90619 |
|
2,510 |
2,503 |
$28K |
| 90660 |
|
2,727 |
2,716 |
$26K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,625 |
8,467 |
$23K |
| 90696 |
|
2,236 |
2,191 |
$23K |
| 90713 |
|
2,405 |
2,376 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
294 |
270 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,030 |
1,000 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
970 |
922 |
$15K |
| 99243 |
|
169 |
167 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
151 |
144 |
$11K |
| 90461 |
|
4,372 |
4,280 |
$8K |
| G9919 |
Screening performed and positive and provision of recommendations |
298 |
295 |
$8K |
| 0071A |
|
186 |
186 |
$7K |
| 0072A |
|
119 |
119 |
$5K |
| 87807 |
|
423 |
378 |
$4K |
| 99383 |
|
44 |
40 |
$3K |
| 90658 |
|
359 |
359 |
$3K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
71 |
69 |
$2K |
| 90674 |
|
236 |
236 |
$2K |
| 90657 |
|
233 |
233 |
$2K |
| 99382 |
|
32 |
28 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
29 |
29 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
313 |
301 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 69210 |
|
2,082 |
1,978 |
$1K |
| 90381 |
|
70 |
70 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
136 |
132 |
$1K |
| 90380 |
|
44 |
44 |
$915.35 |
| 81000 |
|
3,265 |
3,049 |
$846.89 |
| 86580 |
|
91 |
90 |
$683.68 |
| 0001A |
|
14 |
14 |
$560.00 |
| 81002 |
|
5,218 |
4,849 |
$349.62 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
594 |
490 |
$264.43 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
12 |
$97.22 |
| 99177 |
|
170 |
127 |
$0.00 |
| 91300 |
|
38 |
35 |
$0.00 |
| 36416 |
|
1,065 |
970 |
$0.00 |